Corona warning app launched in Germany

16

Jul 2020

The Corona warning app, developed on behalf of the German government, has been available for download in the Google and Apple stores since June 16, 2020. It is intended to help identify and break infection chains at an early stage. Users of the app receive a notification if they have been for a long time in the vicinity of a person who was later found to be infected with the coronavirus.

At the launch of the Corona warning app, the National Association of Statutory Health Insurance Physicians (KBV) and the National Association of Statutory Health Insurance Funds (GKV) have added several new services to the EBM (German Uniform Evaluation Standard) and regulated the reimbursement to compensate for the smear collection and the laboratory testing. As of now, doctors can bill these services for insured persons who come to the practice for a test after the app has warned them. Thereafter, contracted doctors will receive €10 extra for the smear collection together with the basic or insured flat rate.

The smear collection is reimbursed via the new fee order item (GOP) 02402 "Upper airway swab collection (oropharynx and/or nasopharynx smear, irrigation or aspirate)" (Abstrichentnahme aus den oberen Atemwegen (Oropharynx und/oder Nasopharynx-Abstrich, -Spülung oder -Aspirat)) (91 points / €10). It is billable once on the day of treatment and only for insured persons who referred because of an app warning. Smears collection for insured persons with symptoms is still part of the insured or basic flat rate.

There are also new services in EBM for laboratory tests performed due to warnings from the app, including:

  • GOP 32811 “Nucleic acid of the SARS-CoV-2 coronavirus detection due to a warning by the Corona warning app” (Nukleinsäurenachweis des Coronavirus SARS-CoV-2 aufgrund einer Warnung durch die Corona-Warn-App) (€39.40) for nucleic acid detection
  • GOP 12221 (14 points / €1.54) for medical services
  • GOP 40101 “Surcharge for fee order item 32811 in case of sending samples for shipping material, shipping containers, etc., as well as for sending or transporting test material, possibly also infectious test material, including the costs for the submission of test results” (Zuschlag zur Gebührenordnungsposition 32811 bei Probeneinsendung für Versandmaterial, Versandgefäße usw. sowie für die Versendung bzw. den Transport von Untersuchungsmaterial, gegebenenfalls auch von infektiösem Untersuchungsmaterial, einschließlich der Kosten für die Übermittlung von Untersuchungsergebnissen) (€2.60) for the reimbursement of the costs for transport and submission of the test results.

The new GOPs 02402, 32811, 12221 and 40101 can only be billed in connection with the notification of an "increased risk" of the new Corona warning app if the insured person visits a contracted doctor directly.

According to the Robert Koch Institute information, the number of Corona warning app installations reached 10.6 million as of June 20, 2020.

The full details in German can be found here. The corresponding decision of the Evaluation Committee in German can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more